New Objective Announces Upcoming Webinar: FlowChip Standardization – Metabolomics Evaluation
May 4, 2022 – Littleton, MA (USA) New Objective, Inc., the market leader in innovative solutions for nanoflow and microflow LC-MS, announces its upcoming webinar featuring the FlowChip and its integration as a standardized platform for metabolomics. Mike Lee, CEO together with Emily Ehrenfeld, President of New Objective will be welcoming Rafael Melani of Northwestern University to share recent experiences and ongoing work using the FlowChip, a standardized platform in use for Top-Down Proteomics at Northwestern and the launch of an evaluation using FlowChip for metabolomics.
The event, scheduled for Wednesday May 11th, 2022 will feature a format similar to the engaging discussions established by CPSA Everyday, sharing a common focus to standardize, unify and industrialize as told through the framework of technology, solutions and regulations, for the patient. As outlined in the agenda, the discussions will be led by thought leaders across industry who will share insights on developing standardized methods and workflows with a focus on the patient with human samples.
- Welcome
- Mike Lee – New Objective
- Opening Remarks
- Emily Ehrenfeld – New Objective
- Amanda Berg – New Objective
- Background
- Rafael Melani – Northwestern
- Helena Svobodova – New Objective
- Standardization for Metabolomics
- Introduction
- Rafael Melani – Northwestern
- Helena Svobodova – New Objective
- Discussion
- Brad Ackermann – Eli Lilly and Company
- Mark Arnold – LabCorp Drug Development
- Robyn Rourick – Genentech
- Introduction
- Closing Remarks
- Amanda Berg – New Objective
- Emily Ehrenfeld – New Objective
- Adjourn
- Mike Lee – New Objective
Wednesday’s event will be an exclusive event and will build on ongoing discussions as published recently at New Objective in March 2022, November 2021, ASMS in Philadelphia and CPSA Everyday.